GC Wealth Management RIA, LLC

Position in NVO — Novo Nordisk A S

CIK 2011169 Cambridge, MA

Position in NVO

as of Jun 30, 2026 · filed Jul 16, 2026 Compact

Position Value

$1,900,389

+$847,869 QoQ

Shares Held

39,641

+38.4% QoQ

Ownership

0.001%

of shares outstanding

% of Portfolio

0.14%

of 13F equity value

Holder Rank

#389

of 1,348 holders

Holding Since

Dec 2023

11 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

GC Wealth Management RIA, LLC holds $51,496,913 across 12 Drug Manufacturers - General names. NVO ranks #7 (3.7% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co	18,328	$21,983,154
2	ABBV	AbbVie Inc.	37,102	$9,336,347
3	MRK	Merck & Co., Inc.	39,089	$5,022,936
4	JNJ	Johnson & Johnson	18,773	$4,767,778
5	AZN	Astrazeneca PLC	18,143	$3,440,275
6	AMGN	Amgen Inc	6,073	$2,199,154
7	NVO	Novo Nordisk A S This page	39,641	$1,900,389
8	NVS	Novartis AG	6,349	$995,015

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,900,389	39,641	+38.4%	Shares	Sole	2026-07-16
2026-03-31	$1,052,520	28,640	+12.2%	Shares	Sole	2026-05-14
2025-12-31	$1,299,118	25,533	+26.0%	Shares	Defined	2026-01-30
2025-09-30	$1,124,615	20,267	+45.5%	Shares	Sole	2025-11-13
2025-06-30	$961,586	13,932	+47.5%	Shares	Sole	2025-07-17
2025-03-31	$655,721	9,443	-37.0%	Shares	Sole	2025-05-12
2024-12-31	$1,289,611	14,992	-4.4%	Shares	Sole	2025-02-07
2024-09-30	$1,868,089	15,689	+5.0%	Shares	Sole	2024-11-04
2024-06-30	$2,133,820	14,949	+0.4%	Shares	Sole	2024-07-31
2024-03-31	$1,912,389	14,894	+7.0%	Shares	Sole	2024-05-10
2023-12-31	$1,440,334	13,923	—	Shares	Sole	2024-02-12
No filing history on record for this holder in this stock.